During the past decade, Omega Research Consultants conducted 71 clinical trials. In the 10-year time frame, 71 clinical trials started and 50 clinical trials were completed, i.e. on average, 70.4% percent of trials that started reached the finish line to date. In the past 5 years, 28 clinical trials started and 34 clinical trials were completed. i.e. 121.4% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Omega Research Consultants" #1 sponsor was "Pfizer" with 16 trials, followed by "Janssen Research & Development, LLC" with 12 trials sponsored, "Gilead Sciences" with 8 trials sponsored, "Shire" with 5 trials sponsored and "R-Pharm International, LLC" with 5 trials sponsored. Other sponsors include 34 different institutions and companies that sponsored additional 34 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Omega Research Consultants" #1 collaborator was "OCT Clinical Trials" with 3 trials as a collaborator, "Galapagos NV" with 2 trials as a collaborator, "Merck KGaA, Darmstadt, Germany" with 2 trials as a collaborator, "Ono Pharmaceutical Co. Ltd" with 2 trials as a collaborator and "Quintiles, Inc." with 2 trials as a collaborator. Other collaborators include 6 different institutions and companies that were collaborators in the rest 16 trials.

According to Clinical.Site data, the most researched conditions in "Omega Research Consultants" are "Rheumatoid Arthritis" (15 trials), "COVID-19" (5 trials), "Crohn's Disease" (5 trials), "Systemic Lupus Erythematosus" (5 trials) and "Arthritis, Rheumatoid" (3 trials). Many other conditions were trialed in "Omega Research Consultants" in a lesser frequency.

Most popular intervention types in "Omega Research Consultants" are "Drug" (77 trials), "Other" (15 trials) and "Biological" (10 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (52 trials), "Guselkumab" (5 trials), "Filgotinib" (4 trials), "Methotrexate" (4 trials) and "Ontamalimab" (4 trials). Other intervention names were less common.

The vast majority of trials in "Omega Research Consultants" are 79 trials for "All" genders and 4 trials for "Female" genders.

Currently, there are 21 active trials in "Omega Research Consultants". 1 are not yet recruiting, 14 are recruiting, 5 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 46 completed trials in Omega Research Consultants, undefined suspended trials, and 16 terminated clinical trials to date.

Out of the total trials that were conducted in Omega Research Consultants, 8 "Phase 1" clinical trials were conducted, 33 "Phase 2" clinical trials and 39 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 7 trials, and there were also 0 trials that are defined as “Not Applicable".